BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein. (2014)

First Author: Buffa P
Attributed to:  Rigorous Information-theoretic tools for Comparative Interactomics. funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.13-236992

PubMed Identifier: 24297701

Publication URI: http://europepmc.org/abstract/MED/24297701

Type: Journal Article/Review

Volume: 28

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638